All content for Cardio Ed is the property of The Cardio Ed Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Let's talk about contemporary issues in cardiology.
Let's discuss and learn together.
Join me in this quest for knowledge in cardiology.
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients - Finally something works in HFpEF.
Cardio Ed
6 minutes 29 seconds
4 years ago
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients - Finally something works in HFpEF.
#EMPEROR PRESERVED trial was recently published in #NEJM in 2021. It was also presented at #ESC2021.
Heart Failure with Preserved Ejection Fraction (#HFpEF) is responsible of more than half of the cases of heart failure.
It is a difficult to diagnose and difficult to treat condition.
#Emplagliflozin and #dapagloflozin are 2 #SGLT2inhibitors have been found to be useful drugs in the management of #heart failure with reduced ejection fraction. The EMPEROR REDUCED and DAPA-HF trials have proven the efficacy of both these drugs in #heartfailure with reduced ejection (HFrEF).
The #EMPEROR PRESERVED trial tested that whether #emplagliflozin can be useful in the management of Heart Failure with Preserved Ejection Fraction (#HFpEF).
Cardio Ed
Let's talk about contemporary issues in cardiology.
Let's discuss and learn together.
Join me in this quest for knowledge in cardiology.
